Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

SRTS — Sensus Healthcare, Inc. Dilution Risk Tracker

Track SRTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SRTS — Get alerts when the score changes →

As of October 13, 2026, Sensus Healthcare, Inc. (SRTS) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Sensus Healthcare, Inc. has a market capitalization of $48.23M, 16.46M shares outstanding, 45 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track SRTS — Get forecast alerts →

Market Data

Market Cap$48.23M
Shares Outstanding16.46M
Float13.55M
Cash$15.19M
Debt$471.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding16.46MVerified float table or market cache
Public Float13.55MVerified float table or market cache
Market Cap$48.23MMarket data cache
Cash Runway8.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 12.8% shares (2026Q1 vs prior)
45 institutional holders · 4.79M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.30M shares
#2 Pacific Ridge Capital Partners, LLC 796.1K shares
#3 DIMENSIONAL FUND ADVISORS LP 387.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest227.6K
Days to Cover7.8
% of Float1.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

SRTS's DilutionScore has held steady at 43/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202643/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SRTS shares outstanding have decreased 0.0% from 16.47M (Mar 2026) to 16.46M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 03, 202616.46M13.55M▼ 0.93%
Mar 08, 202616.47M13.68M▼ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SRTS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SRTS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SRTS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SRTS
SRTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.